• Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Formulation Development

Accelerating drug development with stable and compliant drug formulations

Syngene offers Formulation Development services to help clients determine optimal dosage levels for therapeutic formulations in oral solid, liquid, and injectable forms. Our integrated services extend to new chemical entities (NCE), late-phase product development, and over-the-counter products with a focus on quality, speed, and cost-efficiency.


Our strong scientific team has broad experience and expertise in collaborative practices with a global customer base for Formulation Development services and analytical support.

We cater to pharmaceutical companies worldwide, providing extensive pre-formulation studies, toxicology formulation, Formulation Development, and analytical method development and validation. Our services include conducting stability studies as per the guidelines of The international council for harmonisation of technical requirements for pharmaceuticals for human use (ICH) and regulatory dossier preparation. We also perform process optimization and scale-up activities, and manufacturing of clinical batches in a current good manufacturing practice (cGMP) environment.


Syngene has a well-established Formulation Development centre that develops and manufactures oral solid and liquid dosage forms including injectable formulations. Our facility’s layout follows cGMP guidelines and Schedule ‘M’ of the Drugs and Cosmetics Act. The laboratory is spread across an area of 6000 square feet and supports Formulation Development for a scale of 0.1 to 5 kilograms.

The entire facility is covered with non-progressive acid proof and anti-fungal modular panels as well as pressure differentials to prevent cross contamination. We have segregated areas for change rooms, air handling unit (AHU) zoning, and man-material flow. The facility has 100% power back-up, abundant portable water, and an adequate waste management system.

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

To view or email, Please share your details view

To download, Please share your details